2) Visceral fat
内脏脂肪
1.
10 weeks later, body weight, visceral fat mass,fasting glucose,fasting insulin,TNF,αand FFAs were determined,and HOMA-IR was calculated by the method HOMA-IR=.
目的:观察正常大鼠在高脂饮食诱导下形成肥胖后,胰岛素敏感性与内脏脂肪及空腹血TNF鄄α、FFAs变化的关系。
2.
Fasting plasma glucose(FPG),HbA1c,fasting insulin and visceral fat were evaluated.
目的:观察罗格列酮治疗对2型糖尿病内脏脂肪含量变化。
3.
Visceral fat results in insulin resistance through secreting multiple active proinflammatory adipokin.
在代谢综合征发展过程中,胰岛素抵抗起主要作用,而胰岛素抵抗与内脏脂肪密切相关。
3) Fat thickness
脂肪厚度
1.
2/3 of human fat are stored on subcutaneous layer, and we attempt to achieve the near infrared (NIR) measurement of body subcutaneous fat thickness which is a key parameter of body fat content.
本课题尝试使用近红外技术研制便携式脂肪厚度测量仪,测量人体特定部位皮下脂肪厚度,从而估计人体脂肪含量,具有简单、快速、实用和直观等特点。
4) visfatin
内脏脂肪素
1.
Effect of exercise on expression of visfatin of visceral fat in high-fat-diet-fed rats;
运动干预对高脂喂养大鼠脂肪组织内脏脂肪素表达的影响
2.
Progress of Visfatin;
内脏脂肪素(visfatin)的研究进展
3.
Expression and significance of visfatin in nonalcoholic fatty liver disease in rat;
内脏脂肪素在大鼠非酒精性脂肪性肝病模型中的变化及作用
5) visceral adipose mass
内脏脂肪量
1.
Relationship between visceral adipose mass and lipid metabolic disorder in high-fat Insulin resistant rats;
胰岛素抵抗大鼠内脏脂肪量与脂代谢紊乱的相关性研究
6) visceral adiposity
内脏脂肪含量
1.
Methods Eighty rats with different visceral adiposity were obtained through high fat feeding and weight loss method and were divided into normal model group,hypso-fat model group and weight relief group.
目的了解大鼠内脏脂肪含量对ghrelin分泌的影响。
补充资料：脑病合并内脏脂肪变性综合征
脑病合并内脏脂肪变性综合征
En?cephalopathy with fatty degeneration of the viscera,Reye syndrome
本病又称“瑞氏综合征”。非炎症性急性脑肿胀，伴有以肝脏为主的内脏脂肪变性。主要发生在小儿时期，以4个月～5岁最多。病因和发病机制不明。诊断要点：①小儿病前一周内先有病毒感染，常见的为上感、水痘和胃肠炎；②较早出现反复呕吐及意识改变；③病情发展迅速，意识障碍或昏迷；④脑脊液正常；⑤肝功能检查有SGOT及SGPT明显增高、血氨增高，凝血酶原时间延长；⑥血清CPK增高；⑦无神经系统限局性体征；⑧神经系统表现和肝功能异常不能用其他疾病解释；⑨活检证实有肝脂肪变性；⑩肝大、过度换气、惊厥、低血糖、乳酸脱氢酶增高。治疗包括：积极支持疗法，抗惊厥、降颅压及肝功能衰竭的治疗等。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条